Guoying Xu - Search Results

Year	Number of Results
2003	1
2004	3
2005	2
2006	1
2007	2
2008	2
2010	1
2011	5
2012	2
2013	1
2014	2
2015	3
2017	2
2018	2
2020	5
2021	8
2022	3

1

LncRNA PROX1-AS1 Facilitates Gastric Cancer Progression via miR-877-5p/PD-L1 Axis.

Guo T, Wang W, Ji Y, Zhang M, Xu G, Lin S. Guo T, et al. Among authors: xu g. Cancer Manag Res. 2021 Mar 19;13:2669-2680. doi: 10.2147/CMAR.S275352. eCollection 2021. Cancer Manag Res. 2021. PMID: 33776485 Free PMC article.

2

A Bayesian adaptive phase I/II platform trial design for pediatric immunotherapy trials.

Mu R, Pan H, Xu G. Mu R, et al. Among authors: xu g. Stat Med. 2021 Jan 30;40(2):382-402. doi: 10.1002/sim.8780. Epub 2020 Oct 22. Stat Med. 2021. PMID: 33094528 Clinical Trial.

3

An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials.

Mu R, Hu Z, Xu G, Pan H. Mu R, et al. Among authors: xu g. BMC Med Res Methodol. 2021 Dec 13;21(1):278. doi: 10.1186/s12874-021-01455-y. BMC Med Res Methodol. 2021. PMID: 34895153 Free PMC article.

4

A two-stage Bayesian adaptive design for minimum effective dose (MinED)-based dosing-finding trials.

Mu R, Xu G, Liu G, Pan H. Mu R, et al. Among authors: xu g. Contemp Clin Trials. 2021 Sep;108:106504. doi: 10.1016/j.cct.2021.106504. Epub 2021 Jul 22. Contemp Clin Trials. 2021. PMID: 34303862 Clinical Trial.

5

Association of Caveolin-1 Expression With Prostate Cancer: A Systematic Review and Meta-Analysis.

Chen P, Zhang YL, Xue B, Xu GY. Chen P, et al. Front Oncol. 2021 Jan 8;10:562774. doi: 10.3389/fonc.2020.562774. eCollection 2020. Front Oncol. 2021. PMID: 33489874 Free PMC article.

6

Synergistic effects of miR-708-5p and miR-708-3p accelerate the progression of osteoporosis.

Wang R, Feng Y, Xu H, Huang H, Zhao S, Wang Y, Li H, Cao J, Xu G, Huang S. Wang R, et al. Among authors: xu g. J Int Med Res. 2020 Dec;48(12):300060520978015. doi: 10.1177/0300060520978015. J Int Med Res. 2020. PMID: 33322976 Free PMC article.

7

Impaired Autophagy Induced by oxLDL/β2GPI/anti-β2GPI Complex through PI3K/AKT/mTOR and eNOS Signaling Pathways Contributes to Endothelial Cell Dysfunction.

Zhang G, He C, Wu Q, Xu G, Kuang M, Wang T, Xu L, Zhou H, Yuan W. Zhang G, et al. Among authors: xu g. Oxid Med Cell Longev. 2021 Jun 14;2021:6662225. doi: 10.1155/2021/6662225. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34221236 Free PMC article.

8

lncRNA TINCR facilities bladder cancer progression via regulating miR‑7 and mTOR.

Xu G, Yang H, Liu M, Niu J, Chen W, Tan X, Sun L. Xu G, et al. Mol Med Rep. 2020 Nov;22(5):4243-4253. doi: 10.3892/mmr.2020.11530. Epub 2020 Sep 22. Mol Med Rep. 2020. PMID: 33000269 Free PMC article.

9

Enhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord Injury.

Wu Z, Li L, Xie F, Xu G, Dang D, Yang Q. Wu Z, et al. Among authors: xu g. J Pharmacol Exp Ther. 2020 Apr;373(1):72-80. doi: 10.1124/jpet.119.264010. Epub 2020 Jan 22. J Pharmacol Exp Ther. 2020. PMID: 31969383 Free PMC article.

10

miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.

Lu R, Yang Z, Xu G, Yu S. Lu R, et al. Among authors: xu g. Biomed Pharmacother. 2018 Sep;105:633-644. doi: 10.1016/j.biopha.2018.06.024. Epub 2018 Jun 10. Biomed Pharmacother. 2018. PMID: 29898430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results